119 related articles for article (PubMed ID: 24038913)
1. Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology Group.
Batra V; Sands SA; Holmes E; Geyer JR; Yates A; Becker L; Burger P; Gilles F; Wisoff J; Allen JC; Pollack IF; Finlay JL
Pediatr Blood Cancer; 2014 Jan; 61(1):151-7. PubMed ID: 24038913
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of children treated for high-grade gliomas: children's oncology group L991 final study report.
Sands SA; Zhou T; O'Neil SH; Patel SK; Allen J; McGuire Cullen P; Kaleita TA; Noll R; Sklar C; Finlay JL
J Clin Oncol; 2012 Mar; 30(9):943-9. PubMed ID: 22355055
[TBL] [Abstract][Full Text] [Related]
4. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
[TBL] [Abstract][Full Text] [Related]
5. Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.
Espinoza JC; Haley K; Patel N; Dhall G; Gardner S; Allen J; Torkildson J; Cornelius A; Rassekh R; Bedros A; Etzl M; Garvin J; Pradhan K; Corbett R; Sullivan M; McGowage G; Stein D; Jasty R; Sands SA; Ji L; Sposto R; Finlay JL
Pediatr Blood Cancer; 2016 Oct; 63(10):1806-13. PubMed ID: 27332770
[TBL] [Abstract][Full Text] [Related]
6. The influence of central review on outcome in malignant gliomas of the spinal cord: the CCG-945 experience.
Bouffet E; Allen JC; Boyett JM; Yates A; Gilles F; Burger PC; Davis RL; Becker LE; Pollack IF; Finlay JL
J Neurosurg Pediatr; 2016 Apr; 17(4):453-9. PubMed ID: 26684767
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of centrally located low-grade glioma in children.
Terashima K; Chow K; Jones J; Ahern C; Jo E; Ellezam B; Paulino AC; Okcu MF; Su J; Adesina A; Mahajan A; Dauser R; Whitehead W; Lau C; Chintagumpala M
Cancer; 2013 Jul; 119(14):2630-8. PubMed ID: 23625612
[TBL] [Abstract][Full Text] [Related]
8. Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH).
Benesch M; Wagner S; Berthold F; Wolff JE
J Neurooncol; 2005 Apr; 72(2):179-83. PubMed ID: 15925999
[TBL] [Abstract][Full Text] [Related]
9. Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.
Sorrell AD; Alonzo TA; Hilden JM; Gerbing RB; Loew TW; Hathaway L; Barnard D; Taub JW; Ravindranath Y; Smith FO; Arceci RJ; Woods WG; Gamis AS
Cancer; 2012 Oct; 118(19):4806-14. PubMed ID: 22392565
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience.
Hyder DJ; Sung L; Pollack IF; Gilles FH; Yates AJ; Davis RL; Boyett JM; Finlay JL
J Neurooncol; 2007 May; 83(1):1-8. PubMed ID: 17252186
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
[TBL] [Abstract][Full Text] [Related]
12. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
Jakacki RI; Cohen KJ; Buxton A; Krailo MD; Burger PC; Rosenblum MK; Brat DJ; Hamilton RL; Eckel SP; Zhou T; Lavey RS; Pollack IF
Neuro Oncol; 2016 Oct; 18(10):1442-50. PubMed ID: 27006176
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.
Gnekow AK; Falkenstein F; von Hornstein S; Zwiener I; Berkefeld S; Bison B; Warmuth-Metz M; Driever PH; Soerensen N; Kortmann RD; Pietsch T; Faldum A
Neuro Oncol; 2012 Oct; 14(10):1265-84. PubMed ID: 22942186
[TBL] [Abstract][Full Text] [Related]
14. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
15. Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials.
Osorio DS; Patel N; Ji L; Sposto R; Stanek J; Gardner SL; Allen JC; Cornelius A; McCowage GB; Termuhlen A; Dunkel IJ; Comito M; Garvin J; Finlay JL
J Neurooncol; 2018 Dec; 140(3):717-725. PubMed ID: 30392092
[TBL] [Abstract][Full Text] [Related]
16. Neurosurgical treatment of oligodendroglial tumors in children and adolescents: a single-institution series of 35 consecutive patients.
Lundar T; Due-Tønnessen BJ; Egge A; Scheie D; Stensvold E; Brandal P
J Neurosurg Pediatr; 2013 Sep; 12(3):241-6. PubMed ID: 23870041
[TBL] [Abstract][Full Text] [Related]
17. The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience.
Pollack IF; Boyett JM; Yates AJ; Burger PC; Gilles FH; Davis RL; Finlay JL;
Neuro Oncol; 2003 Jul; 5(3):197-207. PubMed ID: 12816726
[TBL] [Abstract][Full Text] [Related]
18. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA
J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.
Shaw EG; Wang M; Coons SW; Brachman DG; Buckner JC; Stelzer KJ; Barger GR; Brown PD; Gilbert MR; Mehta MP
J Clin Oncol; 2012 Sep; 30(25):3065-70. PubMed ID: 22851558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
